ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Human embryonic stem cell-derived RPE cell transplantation yields no … – Healio

Human embryonic stem cell-derived RPE cell transplantation yields no …HealioMIAMI — A study under way to evaluate safety and tolerability of subretinal transplantation of human embryonic stem cells in patients with dry age-related macular degeneration so far has yielded no “untoward pathologic reactions,” a speaker said here. …read more   &nbs… Continue reading

2014-02-12 Michael Zand NEWS

Robot vision system picks stem cells – Vision Systems Design

Vision Systems DesignUnder certain conditions, stem cells can be induced to become other types of cell such as blood or muscle cells though a process known as differentiation. Because of this, scientists and researchers can use them to regenerate diseased or damaged tissue. …read more   &nbs… Continue reading

2014-02-12 Michael Zand NEWS

Cancer researchers discover pre-leukemic stem cell at root of AML, relapse – Science Codex

Science Codex(TORONTO, Canada – Feb. 12, 2014) – Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers relapse in … …read more   &nbs… Continue reading

2014-02-12 Michael Zand NEWS

Stem Cells For Darwin: How iPSCs Can Explore Evolution – Forbes

ForbesMaria C.N. Marchetto, Iñigo Narvaiza and their team, working with Fred H. Gage’s Lab at the Salk Institute for Biological Studies in La Jolla, CA, generated lines of induced pluripotent stem cells (iPSCs) from humans, from chimpanzees and from bonobos. …read more   &nbs… Continue reading

2014-02-12 Michael Zand NEWS

Cancer researchers discover pre-leukemic stem cell at root of AML, relapse – EurekAlert (press release)

EurekAlert (press release)(TORONTO, Canada – Feb. 12, 2014) – Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers relapse in …AML Treatment In The Works? Rare Form Of Leukemia Found … Continue reading

2014-02-12 Michael Zand NEWS

Cancer researchers discover pre-leukemic stem cell at root of AML, relapse – Medical Xpress

Cancer researchers discover pre-leukemic stem cell at root of AML, relapseMedical Xpress“Our discovery lays the groundwork to detect and target the pre-leukemic stem cell and thereby potentially stop the disease at a very early stage when it may be more amenable to treatment,” says Dr. Dick, who holds a Canada Research Chair in Stem Cell … Continue reading

2014-02-12 Michael Zand NEWS

Stem cells from baby’s umbilical cord save life of granddad given months to live – Mirror.co.uk

Mirror.co.ukA grandad given just months to live has beaten leukaemia – after getting stem cells from two babies’ umbilical cords. The move was the “only option” to save David Pyne, 60, after all other treatments failed. He was one of the first to have the …Umbilical cord stem cell donation ‘saves’ leukaemia manBBC NewsStem cell … Continue reading

2014-02-12 Michael Zand NEWS

Cytori Therapeutics Inc. (USA) (CYTX) news: Cytori Therapeutics: Global … – Seeking Alpha

Cytori Therapeutics Inc. (USA) (CYTX) news: Cytori Therapeutics: Global …Seeking AlphaThis is not your typical Seeking Alpha article. Although focused on a particular company like most other articles, it will take a look at the bigger picture with regard to patient access to their own stem cells, and try to explain a set of perverse … Continue reading

2014-02-12 Michael Zand NEWS
  • 1
  • …
  • 3,276
  • 3,277
  • 3,278
  • 3,279
  • 3,280
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.